This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Epidemiology

Authoring team

Prevalence of AAA is difficult to estimate since majority are asymptomatic (1).

  • in the UK, prevalence is estimated to be approximately 1.3% in men who enrol in the national screening programme (at age 65) (1,4)

  • a Swedish study involving ultrasonographic screening of 65 year old men reported a decline in the prevalence
    • this is thought to be due to modification of risk factors (especially smoking) (2)

Incidence of AAA is reported to be between 4.9%-9.9% (3)

  • it is rare in people less than 50 years (3).
  • the incidence increases sharply with each decade - starting at 50 years of age for men and 60 to 70 years of age for women
    • incidence of symptomatic AAA in men is approximately 25 per 100,000 at age 50, increasing to 78 per 100,000 in those older than 70 years (1)

It is four to six times more common in men than women.

  • however the risk rupture is higher in women (3)

Around 13,000 deaths occur each year in the USA due to AAA (2). In the UK, mortality after rupture exceeds 80%, accounting for 8000 deaths annually (3).

Most AAAs are asymptomatic, and they are often diagnosed opportunistically during clinical examination or investigation for another condition. Because of this it is difficult to establish their prevalence. There is a national screening programme which enrols men at age 65 and suggests a prevalence of about 1.3% in this population (4)

  • the prevalence is falling
  • the prevalence of AAAs is approximately 6 times lower in women, but the rate of aneurysm rupture is significantly higher.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.